Ten-year longitudinal investigation of DNA methylation in patients with Parkinson’s disease from the DeNoPa cohort

Parkinson's disease exhibits a variable course and various symptoms. Genetic changes have been identified in approximately 10% of cases, while the causes of the remaining cases remain unclear. In addition to genetic information, DNA methylation also influences information transmission within cells. This methylation is to be investigated in the De Novo Parkinson (DeNoPa) cohort over a period of ten years. The objective is to create and compare methylation profiles to identify differences and analyze changes in the course.

Bridge-building between clinic and research

Bad Homburg v.d. Höhe, December 6, 2023 – Optimal compatibility of patient care and research: The foundation Else Kröner-Fresenius-Stiftung (EKFS) is awarding three Else Kröner Clinician Scientist Professorships. This is the fifth time in a row. Each of the professorships is endowed with 1.1 million euros over a maximum of ten years – provided that a positive interim evaluation occurs after five years. One application per faculty was admissible.

Else Kröner Fresenius Symposium for Breakthroughs in Life Sciences

The multifaceted agenda focused on two main themes: “Diseases of Worldwide Significance” and “Technological Breakthroughs in Life Sciences”. A wide-ranging spectrum of topics was offered – from infectious diseases to cardiology and neuro-oncology, all the way to developments in visual prosthesis, artificial photosynthesis and the improvement of crop yields via modifications in gene regulation.

Checking back: What is Dr. Adrian Gottschlich, successful first-round and second-time applicant from 2023, doing these days?

Within the scope of his funded project Adrian Gottschlich is developing targeted new immunotherapies for (young) patients with Hodgkin’s lymphomas (cancer of the lymph nodes) by means of computer-aided bioinformatic analyses. These new and specific therapeutic options are intended to contribute toward alleviating long-term side effects associated with chemotherapy and improving the survival rate for these patients.

Getting started on a professional career as Clinician Scientist

Bad Homburg v.d. Höhe, November 30, 2023 – The foundation Else Kröner-Fresenius-Stiftung (EKFS) is supporting medical faculties and university hospitals in Germany through three Else Kröner Research Schools for Physicians, each of which is endowed with 1.3 million euros. The Research Schools are intended to provide talented young physicians with an ideal environment for their research work and enable access to a successful career as Clinician Scientist.

Clinician Scientist Professur für Seltene Erkrankungen (only available in German)

Für Seltene Erkrankungen ergibt sich durch den rasanten technologischen Fortschritt ein hohes Potential für diagnostische und therapeutische Innovationen, die am besten durch Ärztinnen und Ärzte umgesetzt werden können, die klinische Tätigkeit und Forschung in ihrer Berufstätigkeit verbinden (Clinician Scientist).